# US 2020/0390840 A1 · Method for separating eight components in chinese traditional medicine composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0390840 A1
- Document ID: US20200390840A1
- Status: Published application
- Kind: A1
- Application number: 16/761,780
- Filed: 2018-10-25
- Published: 2020-12-17
- Earliest claimed: 2017-11-10
- Assignees: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
- Applicants: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
- Inventors: Chuangfeng Zhang; Shuo Shen; Lianqiang Song
- Web page: https://patentgrep.com/patent/US20200390840A1

## CPC

- B01D 15/265: {Adsorption chromatography}
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 36/11: Pteridophyta or Filicophyta (ferns)
- A61K 36/17: Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
- A61K 36/315: Isatis, e.g. Dyer's woad
- A61K 36/41: Crassulaceae (Stonecrop family)
- A61K 36/484: Glycyrrhiza (licorice)
- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/634: Forsythia
- A61K 36/708: Rheum (rhubarb)
- A61K 36/736: Prunus, e.g. plum, cherry, peach, apricot or almond
- A61K 36/78: Saururaceae (Lizard's-tail family)
- B01D 15/1864: {using two or more columns}
- B01D 15/1867: {with intermediate treatments or steps performed between columns}
- B01D 15/325: {Reversed phase}
- B01D 15/34: Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
- C07C 67/48: Separation; Purification; Stabilisation; Use of additives
- C07C 67/56: by solid-liquid treatment; by chemisorption
- C07C 69/732: of unsaturated hydroxy carboxylic acids
- C07H 1/08: from natural products
- C07H 15/244: Anthraquinone radicals, e.g. sennosides
- C07H 15/26: Acyclic or carbocyclic radicals, substituted by hetero rings
- C07H 17/04: Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H 17/07: Benzo[b]pyran-4-ones
- A61K 2236/13: involving cleaning, e.g. washing or peeling
- A61K 2236/15: involving mechanical treatment, e.g. chopping up, cutting or grinding
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/39: Complex extraction schemes, e.g. fractionation or repeated extraction steps
- B01D 15/166: {Fluid composition conditioning, e.g. gradient}
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The solution provides a method for separating a Chinese traditional medicine composition. To explain a pharmacological effect mechanism of a medicine made of two or more components and scientific content in rules of compatibility among components of a compound medicine, systematic researches on the material basis is very necessary. Accordingly, deep researches are done on chemical components of the pharmaceutical composition in the solution, and eight compounds are separated, which are 10-O-(p-hydroxycinnamoyl)-adoxosidic acid, aloe-emodin-8-O-β-D-glucopyranoside, quercitrin, matairesinol-4-O-glucoside, liquiritin apioside, epi-vogeloside, vogeloside and ethyl caffeate, which provides a new quality control method for the composition in the solution.

## Claims

### Claim at position 1

-10. (canceled)

### Claim 11

A method for separating eight components in a Chinese traditional medicine composition, wherein the Chinese traditional medicine composition is prepared from raw materials in parts by weight comprising: 200-300 parts of fructusforsythiae, 60-100 parts of ephedra, 40-60 parts of rheum officinale, 200-300 parts of houttuyniacordata, 200-300 parts of honeysuckle, 200-300 parts of isatis root, 60-100 parts of pogostemoncablin, 200-300 parts of rhizomadryopteriscrassirhizomatis, 60-100 parts of rhodiolarosea, 5-9 parts of menthol, 60-100 parts of semen armeniacaeamarum, 60-100 parts of liquorice and 200-300 parts of gypsum fibrosum, wherein the method comprises following steps of:
(1) adsorbing total extract of the Chinese traditional medicine composition by AB-8 macroporous resin, eluting with water, 10% ethanol, 30% ethanol and 50% ethanol in sequence, respectively collecting eluent of each part, and concentrating to obtain extract of each part;
(2) taking the extract of an elution part of the 50% ethanol (50% ethanol elution part extract) obtained in step (1), adding reverse-phase silica gel ODS-AQ-HG, naturally airing a mixed sample, loading the mixed sample, separating by using a reverse-phase ODS-AQ-HG open column, and sequentially eluting by using methanol with methanol-water volume ratios of 20:80, 40:60, 60:40, 80:20 and 100% methanol, and sequentially obtaining Fr.A-Fr.E samples;
(3) taking the Fr.A sample obtained in step (2), adding a reverse-phase silica gel ODS-AQ-HG to a mix sample, naturally airing the mixed sample ODS, adding the mixed sample ODS into a sample loading column, separating a liquid phase prepared by an upper medium-pressure, gradiently separating a liquid phase prepared by a medium-pressure, wherein a volume ratio of methanol to water is 25:75-60:40, and a flow rate is 25 mL/min, receiving fractions in equal volume of 500 mL in a conical flask, concentrating under reduced pressure, identifying combined fractions through a thin layer chromatography plate, and concentrating under reduced pressure again to obtain Fr.A-1-Fr.A-7 samples;
(4) mixing the Fr. A-2 sample obtained in the step (3) with silica gel, loading onto a silica gel column, carrying out isocratic separation by using a dichloromethane-methanol volume ratio of 8:1, receiving fractions in equal volume of 50 mL, eluting with a volume of 800 mL, and identifying combined fractions through thin-layer chromatography plate to obtain Fr.A-1-1-Fr.A-1-4 samples;
(5) dissolving the Fr. A-1-2 sample obtained in the step (4) with methanol, adopting high performance liquid chromatography, wherein a volume ratio of methanol to water in a mobile phase is 50:50, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, to perform primary separation, and respectively collecting chromatographic peaks with retention times of 6-8 min, 9-10 min and 12-13 min, recovering the solvent under reduced pressure, and respectively performing following separation:
a chromatographic peak of 6-8 min, further purified by high performance liquid chromatography, wherein a volume ratio of acetonitrile to water in the mobile phase is 25:75, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 8-9 min, recovering the solvent under decompression to obtained a compound 2: aloe-emodin-8-O-3-D-glucopyranoside;
a chromatographic peak of 9-10 min, further purified by high performance liquid chromatography, wherein a volume ratio of methanol to water in a mobile phase is 45:55, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 21-23 min, recovering the solvent under decompression to obtained a compound 3: quercitrin; and
a chromatographic peak of 10-12 min, further purified by high performance liquid chromatography, wherein a volume ratio of acetonitrile to water in a mobile phase is 25: 75, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 9-10 min, recovering the solvent under decompression to obtained a compound 4: matairesinol-4′-O-glucoside;
(6) dissolving the Fr. A-1-3 sample obtained in the step (4) with methanol, adopting high performance liquid chromatography, wherein a volume ratio of methanol to water in a mobile phase is 30:70, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, to perform primary separation and respectively collecting chromatographic peaks with retention times of 10-11 min, 17-19 min and 21-24 min, recovering the solvent under reduced pressure, chromatographic peaks at 17-19 min is for a compound 6: epi-vogeloside, chromatographic peaks at 21-24 min is for a compound 7: vogeloside, chromatographic peak of 10-11 min, further purified by high performance liquid chromatography, wherein a volume ratio of acetonitrile to water in a mobile phase is 15:85, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 14-16 min, recovering the solvent under decompression to obtained a compound 5: liquiritin apioside; and
(7) dissolving the Fr. A-3 sample obtained in the step (3) with methanol, adopting high performance liquid chromatography, wherein a volume ratio of methanol to water in a mobile phase is 60:40, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, to perform primary separation and respectively collecting chromatographic peaks with retention times of 14-15 min and 19-21 min, and recovering the solvent under reduced pressure, separating out a white precipitate in a dichloromethane-methanol solution with volume ratio of 2:1 from a collecting liquid ofchromatographic peak of 19-21 min to obtain a compound 8; and
wherein chromatographic peak of 14-15 min is further purified by high performance liquid chromatography, wherein a volume ratio of acetonitrile to water in a mobile phase is 30:70, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 18-20 min, recovering the solvent under decompression to obtained a compound 1: 10-O-(p-hydroxycinnamoyl)-adoxosidic acid.

### Claim 12

The method for separating the eight components according to claim ii, wherein the Chinese traditional medicine composition is further prepared from following raw materials in parts by weight:
200 parts of fructusforsythiae, 300 parts of honeysuckle, 200 parts of isatis root, 40 parts of rheum officinale, 60 parts of pogostemoncablin, 300 parts of rhizomadryopteriscrassirhizomatis, 100 parts of rhodiolarosea, 9 parts of menthol, 60 parts of ephedra, 100 parts of semen armeniacaeamarum, 200 parts of houttuyniacordata, 100 parts of liquorice and 200 parts of gypsum fibrosum.

### Claim 13 (depends on 11)

The method for separating the eight components according to claim 11, wherein the Chinese traditional medicine composition is further prepared from following raw materials in parts by weight:
300 parts of fructusforsythiae, 200 parts of honeysuckle, 300 parts of isatis root, 60 parts of rheum officinale, 100 parts of pogostemoncablin, 200 parts of rhizomadryopteriscrassirhizomatis, 60 parts of rhodiolarosea, 5 parts of menthol, 100 parts of ephedra, 60 parts of semen armeniacaeamarum, 300 parts of houttuyniacordata, 60 parts of liquorice and 300 parts of gypsum fibrosum.

### Claim 14 (depends on 11)

The method for separating the eight components according to claim 11, wherein the Chinese traditional medicine composition is further prepared from following raw materials in parts by weight:
278 parts of fructusforsythiae, 294 parts of honeysuckle, 285 parts of isatis root, 55 parts of rheum officinale, 95 parts of pogostemoncablin, 290 parts of rhizomadryopteriscrassirhizomatis, 87 parts of rhodiolarosea, 8.5 parts of menthol, 88 parts of ephedra, 80 parts of semen armeniacaeamarum, 284 parts of houttuyniacordata, 95 parts of liquorice and 277 parts of gypsum fibrosum.

### Claim 15 (depends on 11)

The method for separating the eight components according to claim 11, wherein the total extract of the Chinese traditional medicine composition is prepared by following steps of:
(8) weighing materials of the Chinese traditional medicine composition according to a weight ratio of the raw materials, cleaning and selecting, and crushing the materials as appropriate;
(9) crushing pogostemoncablin, adding 10 times of water to extract volatile oil, extracting for 8 hours, and collecting the volatile oil for later use; and after filtering extracting solution, discarding the residue, and taking first filtrate for later use;
(10) extracting fructusforsythiae, ephedra, houttuyniacordata and rheum officinale three times with 12 times of 70% ethanol for 2.5 hours each time, combining and filtering extracting solutions, recovering ethanol, and taking second filtrate for later use;
(11) honeysuckle, gypsum fibrosum, isatis root, rhizomadryopteriscrassirhizomatis, liquorice and rhodiolarosea, adding 12 times of water for decocting to boil, adding semen armeniacaeamarum, decocting twice for 1 hour each time, combining and filtering extracting solutions, combining obtained third filtrate with the first filtrate after pogostemoncablin oil extraction in the step (9), concentrating to a clear paste with a relative density of 1.10-1.15 measured at 60° C., adding ethanol to adjust alcohol concentration to 70%, and refrigerating and standing; filtering and recovering ethanol until no alcohol smell exists to obtain clear paste for later use; and
(12) combining the clear paste obtained in the step (11) with alcohol extract obtained in the step (10), concentrating to a clear paste with a relative density of 1.15-1.20 measured at 60° C., and drying to obtain the total extract for later use.

### Claim 16

The method for separating the eight components according to claim ii, further comprising following steps of:
(8) adsorbing 5 kg the total extract of the Chinese traditional medicine composition by AB-8 macroporous resin, eluting with 150 L water, 87.5 L 10% ethanol, 225 L 30% ethanol and 250 L 50% ethanol in sequence, and concentrating to obtain extract of each part;
(9) taking 200 g of the 50% ethanol elution part extract obtained in the step (8), adding 200 g reversed-phase silica gel ODS-AQ-HG S-50 μm to a second mix sample ODS, naturally airing the second mixed sample ODS, loading the second mixed sample ODS, and separating by using a reversed-phase ODS-AQ-HG S-50 μm open column, wherein a sample height ratio is 1:4, eluting with 6 L methanol-water in a volume ratio of 20:80, 7 L in a volume ratio 40:60, 7 L in a volume ratio 60:40, 5 L in a volume ratio 80:20 and 3 L 100% methanol in sequence under reduced pressure to obtain the Fr.A-Fr.E samples;
(10) taking 50.0 g of the Fr.A sample obtained in step (9), adding 50 g of reverse-phase silica gel ODS-AQ-HG S-50 μm to a third mix sample ODS, naturally airing the third mixed sample ODS, adding the third mixed sample ODS into a sample loading column, separating a liquid phase prepared by an upper medium-pressure, wherein a separating column filler is ODS-AQ-HG S-50 μm, gradiently separating liquid phase prepared by medium-pressure, wherein a volume ratio of methanol to water is 25:75-60:40, and a flow rate is 25 mL/min, receiving fractions in equal volume of 500 mL in a conical flask, concentrating under reduced pressure, identifying combined fractions through a thin layer chromatography plate, and concentrating under reduced pressure again to obtain the Fr.A-1-Fr.A-7 samples;
(11) mixing 3.2 g of the Fr.A-2 sample obtained in the step (io) with 6.4 g silica gel of 200-300 mesh, loading onto a silica gel column, wherein a sample height ratio is 1:50, carrying out isocratic separation by using a dichloromethane-methanol volume ratio of 8:1, receiving fractions in equal volume of 50 mL, eluting with a volume of 800 mL, and identifying combined fractions through thin-layer chromatography plate to obtain the Fr.A-1-1-FLA-1-4 samples;
(12) dissolving the Fr. A-1-2 sample obtained in the step (11) with methanol to generate a solution, wherein the solution is filtered through a 0.45 μm microporous membrane, adopting high performance liquid chromatography, wherein a volume ratio of methanol to water in a mobile phase is 50:50, a flow rate is 12 mL/min, and a detection wavelength is 210 nm, to perform primary separation and respectively collecting chromatographic peaks with retention times of 6-8 min, 9-1 min and 12-13 min, recovering the solvent under reduced pressure, and respectively performing following separation:
the chromatographic peak of 6-8 min, further purified by high performance liquid chromatography, wherein the volume ratio of acetonitrile to water in the mobile phase is 25:75, the flow rate is 12 mL/min, and the detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 8-9 min, recovering the solvent under decompression to obtained the compound 2: aloe-emodin-8-O-β-D-glucopyranoside; and
the chromatographic peak of 9-10 min, further purified by high performance liquid chromatography, wherein the volume ratio of methanol to water in the mobile phase is 45:55, the flow rate is 12 mL/min, and the detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 21-23 min, recovering the solvent under decompression to obtained the compound 3: quercitrin;
the chromatographic peak of 10-12 min, further purified by high performance liquid chromatography, wherein the volume ratio of acetonitrile to water in the mobile phase is 25:75, the flow rate is 12 mL/min, and the detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 9-10 min, recovering the solvent under decompression to obtained the compound 4: matairesinol-4′-O-glucoside;
(13) dissolving the Fr. A-1-3 sample obtained in the step (11) with methanol, the solution is filtered through a 0.45 μm microporous membrane, adopting high performance liquid chromatography, wherein the volume ratio of methanol to water in the mobile phase is 30:70, the flow rate is 12 mL/min, and detection wavelength is 210 nm, to perform primary separation and respectively collecting chromatographic peaks with retention times of 10-11 min, 17-19 min and 21-24 min, recovering the solvent under reduced pressure, the chromatographic peaks of 17-19 min is for the compound 6: epi-vogeloside, the chromatographic peaks of 21-24 min is for the compound 7: vogeloside, the chromatographic peak of 10-11 min, further purified by high performance liquid chromatography, wherein the volume ratio of acetonitrile to water in the mobile phase is 15:85, the flow rate is 12 mL/min, and the detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 14-16 min, recovering the solvent under decompression to obtained the compound 5: liquiritin apioside; and
(14) dissolving the Fr. A-3 sample obtained in the step (10) with methanol, the solution is filtered through a 0.45 μm microporous membrane, adopting high performance liquid chromatography, wherein the volume ratio of methanol to water in the mobile phase is 60:40, the flow rate is 12 mL/min, and detection wavelength is 210 nm, to perform primary separation and respectively collecting chromatographic peaks with retention times of 14-15 min and 19-21 min, and recovering the solvent under reduced pressure, separating out a white precipitate in a dichloromethane-methanol solution with volume ratio of 2:1 from a collecting liquid ofchromatographic peak of 19-21 min to obtain the compound 8; and wherein the chromatographic peak of 14-15 min is further purified by high performance liquid chromatography, wherein the volume ratio of acetonitrile to water in the mobile phase is 30:70, the flow rate is 12 mL/min, and the detection wavelength is 210 nm, chromatographic column: YMC-Pack R&D ODS-A, 250×20 mm, S-10 μm, under these conditions, collecting the chromatographic peak with retention times of 18-20 min, recovering the solvent under decompression to obtained the compound 1: 10-O-(p-hydroxycinnamoyl)-adoxosidic acid.

### Claim 17 (depends on 16)

The method for separating the eight components according to claim 16, wherein the Chinese traditional medicine composition is further prepared from following raw materials in parts by weight:
200 parts of fructusforsythiae, 300 parts of honeysuckle, 200 parts of isatis root, 40 parts of rheum officinale, 60 parts of pogostemoncablin, 300 parts of rhizomadryopteriscrassirhizomatis, 100 parts of rhodiolarosea, 9 parts of menthol, 60 parts of ephedra, 100 parts of semen armeniacaeamarum, 200 parts of houttuyniacordata, 100 parts of liquorice and 200 parts of gypsum fibrosum.

### Claim 18 (depends on 16)

The method for separating the eight components according to claim 16, wherein the Chinese traditional medicine composition is further prepared from following raw materials in parts by weight:
300 parts of fructusforsythiae, 200 parts of honeysuckle, 300 parts of isatis root, 60 parts of rheum officinale, 100 parts of pogostemoncablin, 200 parts of rhizomadryopteriscrassirhizomatis, 60 parts of rhodiolarosea, 5 parts of menthol, 100 parts of ephedra, 60 parts of semen armeniacaeamarum, 300 parts of houttuyniacordata, 60 parts of liquorice and 300 parts of gypsum fibrosum.

### Claim 19 (depends on 16)

The method for separating the eight components according to claim 16, wherein the Chinese traditional medicine composition is further prepared from following raw materials in parts by weight:
278 parts of fructusforsythiae, 294 parts of honeysuckle, 285 parts of isatis root, 55 parts of rheum officinale, 95 parts of pogostemoncablin, 290 parts of rhizomadryopteriscrassirhizomatis, 87 parts of rhodiolarosea, 8.5 parts of menthol, 88 parts of ephedra, 80 parts of semen armeniacaeamarum, 284 parts of houttuyniacordata, 95 parts of liquorice and 277 parts of gypsum fibrosum.

### Claim 20 (depends on 16)

The method for separating the eight components according to claim 16, wherein the total extract of the Chinese traditional medicine composition is prepared by following steps of:
(15) weighing materials of the Chinese traditional medicine composition according to a weight ratio of the raw materials, cleaning and selecting, and crushing the materials as appropriate;
(16) crushing pogostemoncablin, adding 10 times of water to extract volatile oil, extracting for 8 hours, and collecting the volatile oil for later use; and after filtering extracting solution, discarding the residue, and taking first filtrate for later use;
(17) extracting fructusforsythiae, ephedra, houttuyniacordata and rheum officinale three times with 12 times of 70% ethanol for 2.5 hours each time, combining and filtering extracting solutions, recovering ethanol, and taking second filtrate for later use;
(18) honeysuckle, gypsum fibrosum, isatis root, rhizomadryopteriscrassirhizomatis, liquorice and rhodiolarosea, adding 12 times of water for decocting to boil, adding semen armeniacaeamarum, decocting twice for 1 hour each time, combining and filtering extracting solutions, combining obtained third filtrate with the first filtrate after pogostemoncablin oil extraction in the step (16), concentrating to a clear paste with a relative density of 1.10-1.15 measured at 60° C., adding ethanol to adjust alcohol concentration to 70%, and refrigerating and standing; filtering and recovering ethanol until no alcohol smell exists to obtain clear paste for later use; and
(19) combining the clear paste obtained in the step (18) with alcohol extract obtained in the step (17), concentrating to a clear paste with a relative density of 1.15-1.20 measured at 60° C., and drying to obtain the total extract for later use.
